BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhai HY, Liang P, Yu J, Cao F, Kuang M, Liu FY, Zhu XY. Comparison of sonazoid and sonoVue in the diagnosis of focal liver lesions: A preliminary study. J Ultrasound Med. 2019;38:2417-2425. [PMID: 30680779 DOI: 10.1002/jum.14940] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Kang H, Lee JM, Yoon JH, Lee K, Kim H, Han JK. Contrast-enhanced US with Sulfur Hexafluoride and Perfluorobutane for the Diagnosis of Hepatocellular Carcinoma in Individuals with High Risk. Radiology 2020;297:108-16. [DOI: 10.1148/radiol.2020200115] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
2 Blohm KO, Tichy A, Nell B. Clinical utility, dose determination, and safety of ocular contrast-enhanced ultrasonography in horses: A pilot study. Vet Ophthalmol 2020;23:331-40. [PMID: 31799804 DOI: 10.1111/vop.12730] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Song X, Wang S, Zhao C, Zhang W, Wang G, Jia S. Visual method for evaluating liver function: targeted in vivo fluorescence imaging of the asialoglycoprotein receptor. Biomed Opt Express 2019;10:5015-24. [PMID: 31646026 DOI: 10.1364/BOE.10.005015] [Reference Citation Analysis]
4 Yang Y, Liu C, Yan J, Liu K. Perfluorobutane contrast-enhanced ultrasonography for the diagnosis of HCC: a systematic review and meta-analysis. Abdom Radiol (NY) 2021;46:4619-28. [PMID: 34086090 DOI: 10.1007/s00261-021-03141-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Chen Y, Wang W. Differentiation between hepatocellular carcinoma and intrahepatic cholangiocarcinoma using contrast-enhanced ultrasound: A systematic review and meta-analysis. Clin Hemorheol Microcirc 2021. [PMID: 33935070 DOI: 10.3233/CH-211145] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Wang JY, Luo Y, Wang WY, Zheng SC, He L, Xie CY, Peng L. Contrast-enhanced ultrasound using SonoVue mixed with oral gastrointestinal contrast agent to evaluate esophageal hiatal hernia: Report of three cases and a literature review. World J Clin Cases 2021; 9(11): 2679-2687 [PMID: 33889636 DOI: 10.12998/wjcc.v9.i11.2679] [Reference Citation Analysis]
7 Li X, Han X, Li L, Su C, Sun J, Zhan C, Feng D, Cheng W. Dynamic Contrast-Enhanced Ultrasonography with Sonazoid for Diagnosis of Microvascular Invasion in Hepatocellular Carcinoma. Ultrasound in Medicine & Biology 2021. [DOI: 10.1016/j.ultrasmedbio.2021.11.005] [Reference Citation Analysis]
8 Chen K, Dong Y, Zhang W, Han H, Mao F, Zhang Q, Zheng Z, He W, Wang WP. Analysis of contrast-enhanced ultrasound features of hepatocellular adenoma according to different pathological molecular classifications. Clin Hemorheol Microcirc 2020;76:391-403. [PMID: 32675402 DOI: 10.3233/CH-200899] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Miwa H, Numata K, Sugimori K, Kaneko T, Maeda S. Vascular evaluation using transabdominal ultrasound for gallbladder polyps. J Med Ultrasonics 2021;48:159-73. [DOI: 10.1007/s10396-020-01008-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Sun Y, Cui L, Wang S, Shi T, Hao Y, Lei Y. Comparative study of two contrast agents for intraoperative identification of sentinel lymph nodes in patients with early breast cancer. Gland Surg 2021;10:1638-45. [PMID: 34164308 DOI: 10.21037/gs-21-87] [Reference Citation Analysis]
11 Wu J, Ge L, Lu L. Letter to the editor on "Perfluorobutane contrast-enhanced ultrasonography for the diagnosis of HCC: a systematic review and meta-analysis". Abdom Radiol (NY) 2022;47:903-4. [PMID: 34748043 DOI: 10.1007/s00261-021-03338-8] [Reference Citation Analysis]
12 Frinking P, Segers T, Luan Y, Tranquart F. Three Decades of Ultrasound Contrast Agents: A Review of the Past, Present and Future Improvements. Ultrasound in Medicine & Biology 2020;46:892-908. [DOI: 10.1016/j.ultrasmedbio.2019.12.008] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 18.0] [Reference Citation Analysis]
13 He M, Zhu L, Huang M, Zhong L, Ye Z, Jiang T. Comparison Between SonoVue and Sonazoid Contrast-Enhanced Ultrasound in Characterization of Focal Nodular Hyperplasia Smaller Than 3 cm. J Ultrasound Med 2020. [PMID: 33305869 DOI: 10.1002/jum.15589] [Reference Citation Analysis]
14 Marschner CA, Rübenthaler J, Froelich MF, Schwarze V, Clevert DA. Benefits of contrast-enhanced ultrasonography for interventional procedures. Ultrasonography 2021;40:207-16. [PMID: 33530676 DOI: 10.14366/usg.20083] [Reference Citation Analysis]
15 Tenuta M, Sesti F, Bonaventura I, Mazzotta P, Pofi R, Gianfrilli D, Pozza C. Use of contrast enhanced ultrasound in testicular diseases: A comprehensive review. Andrology 2021. [PMID: 34043256 DOI: 10.1111/andr.13057] [Reference Citation Analysis]
16 Barr RG, Huang P, Luo Y, Xie X, Zheng R, Yan K, Jing X, Luo Y, Xu H, Fei X, Lee JM. Contrast-enhanced ultrasound imaging of the liver: a review of the clinical evidence for SonoVue and Sonazoid. Abdom Radiol (NY) 2020;45:3779-88. [PMID: 32424608 DOI: 10.1007/s00261-020-02573-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
17 Wang F, Numata K, Nihonmatsu H, Okada M, Maeda S. Application of new ultrasound techniques for focal liver lesions. J Med Ultrason (2001) 2020;47:215-37. [PMID: 31950396 DOI: 10.1007/s10396-019-01001-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]